These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
207 related articles for article (PubMed ID: 22592891)
1. Long-term administration of AMD3100, an antagonist of SDF-1/CXCR4 signaling, alters fracture repair. Toupadakis CA; Wong A; Genetos DC; Chung DJ; Murugesh D; Anderson MJ; Loots GG; Christiansen BA; Kapatkin AS; Yellowley CE J Orthop Res; 2012 Nov; 30(11):1853-9. PubMed ID: 22592891 [TBL] [Abstract][Full Text] [Related]
2. Effect of SDF-1/Cxcr4 Signaling Antagonist AMD3100 on Bone Mineralization in Distraction Osteogenesis. Xu J; Chen Y; Liu Y; Zhang J; Kang Q; Ho K; Chai Y; Li G Calcif Tissue Int; 2017 Jun; 100(6):641-652. PubMed ID: 28303319 [TBL] [Abstract][Full Text] [Related]
3. SDF-1 promotes endochondral bone repair during fracture healing at the traumatic brain injury condition. Liu X; Zhou C; Li Y; Ji Y; Xu G; Wang X; Yan J PLoS One; 2013; 8(1):e54077. PubMed ID: 23349789 [TBL] [Abstract][Full Text] [Related]
5. The optimal time to inject bone mesenchymal stem cells for fracture healing in a murine model. Wang X; Wang C; Gou W; Xu X; Wang Y; Wang A; Xu W; Guo Q; Liu S; Lu Q; Meng H; Yuan M; Peng J; Lu S Stem Cell Res Ther; 2018 Oct; 9(1):272. PubMed ID: 30359311 [TBL] [Abstract][Full Text] [Related]
6. Stromal cell-derived factor 1/CXCR4 signaling is critical for the recruitment of mesenchymal stem cells to the fracture site during skeletal repair in a mouse model. Kitaori T; Ito H; Schwarz EM; Tsutsumi R; Yoshitomi H; Oishi S; Nakano M; Fujii N; Nagasawa T; Nakamura T Arthritis Rheum; 2009 Mar; 60(3):813-23. PubMed ID: 19248097 [TBL] [Abstract][Full Text] [Related]
7. SDF-1/CXCR4 axis in Tie2-lineage cells including endothelial progenitor cells contributes to bone fracture healing. Kawakami Y; Ii M; Matsumoto T; Kuroda R; Kuroda T; Kwon SM; Kawamoto A; Akimaru H; Mifune Y; Shoji T; Fukui T; Kurosaka M; Asahara T J Bone Miner Res; 2015 Jan; 30(1):95-105. PubMed ID: 25130304 [TBL] [Abstract][Full Text] [Related]
9. Inhibition of SDF-1α/CXCR4 Signalling in Subchondral Bone Attenuates Post-Traumatic Osteoarthritis. Dong Y; Liu H; Zhang X; Xu F; Qin L; Cheng P; Huang H; Guo F; Yang Q; Chen A Int J Mol Sci; 2016 Jun; 17(6):. PubMed ID: 27322244 [TBL] [Abstract][Full Text] [Related]
10. CXCR4 antagonism attenuates load-induced periosteal bone formation in mice. Leucht P; Temiyasathit S; Russell A; Arguello JF; Jacobs CR; Helms JA; Castillo AB J Orthop Res; 2013 Nov; 31(11):1828-38. PubMed ID: 23881789 [TBL] [Abstract][Full Text] [Related]
11. SDF-1 and CXCR4 play an important role in adult SVZ lineage cell proliferation and differentiation. Zhu C; Yao WL; Tan W; Zhang CH Brain Res; 2017 Feb; 1657():223-231. PubMed ID: 27288704 [TBL] [Abstract][Full Text] [Related]
12. CXCR4 antagonist delivery on decellularized skin scaffold facilitates impaired wound healing in diabetic mice by increasing expression of SDF-1 and enhancing migration of CXCR4-positive cells. Liu H; Liu H; Deng X; Chen M; Han X; Yan W; Wang N Wound Repair Regen; 2017 Aug; 25(4):652-664. PubMed ID: 28783870 [TBL] [Abstract][Full Text] [Related]
13. A critical role of Src family kinase in SDF-1/CXCR4-mediated bone-marrow progenitor cell recruitment to the ischemic heart. Cheng M; Huang K; Zhou J; Yan D; Tang YL; Zhao TC; Miller RJ; Kishore R; Losordo DW; Qin G J Mol Cell Cardiol; 2015 Apr; 81():49-53. PubMed ID: 25655934 [TBL] [Abstract][Full Text] [Related]
14. Modulation of stromal cell-derived factor-1/CXC chemokine receptor 4 axis enhances rhBMP-2-induced ectopic bone formation. Wise JK; Sumner DR; Virdi AS Tissue Eng Part A; 2012 Apr; 18(7-8):860-9. PubMed ID: 22035136 [TBL] [Abstract][Full Text] [Related]
15. Parathyroid hormone is a DPP-IV inhibitor and increases SDF-1-driven homing of CXCR4(+) stem cells into the ischaemic heart. Huber BC; Brunner S; Segeth A; Nathan P; Fischer R; Zaruba MM; Vallaster M; Theiss HD; David R; Gerbitz A; Franz WM Cardiovasc Res; 2011 Jun; 90(3):529-37. PubMed ID: 21245057 [TBL] [Abstract][Full Text] [Related]
16. Altered expression of SDF-1 and CXCR4 during fracture healing in diabetes mellitus. Arakura M; Lee SY; Takahara S; Okumachi E; Iwakura T; Fukui T; Nishida K; Kurosaka M; Kuroda R; Niikura T Int Orthop; 2017 Jun; 41(6):1211-1217. PubMed ID: 28412763 [TBL] [Abstract][Full Text] [Related]
17. Chronic AMD3100 antagonism of SDF-1alpha-CXCR4 exacerbates cardiac dysfunction and remodeling after myocardial infarction. Dai S; Yuan F; Mu J; Li C; Chen N; Guo S; Kingery J; Prabhu SD; Bolli R; Rokosh G J Mol Cell Cardiol; 2010 Oct; 49(4):587-97. PubMed ID: 20655922 [TBL] [Abstract][Full Text] [Related]
19. The CXCR4 antagonist AMD3100 suppresses hypoxia-mediated growth hormone production in GH3 rat pituitary adenoma cells. Yoshida D; Koketshu K; Nomura R; Teramoto A J Neurooncol; 2010 Oct; 100(1):51-64. PubMed ID: 20309720 [TBL] [Abstract][Full Text] [Related]
20. Inhibition of SDF-1/CXCR4 Axis to Alleviate Abnormal Bone Formation and Angiogenesis Could Improve the Subchondral Bone Microenvironment in Osteoarthritis. Qin H; Zhao X; Hu YJ; Wang S; Ma Y; He S; Shen K; Wan H; Cui Z; Yu B Biomed Res Int; 2021; 2021():8852574. PubMed ID: 34136574 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]